Cas:100208-62-6 2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione manufacturer & supplier

We serve Chemical Name:2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione CAS:100208-62-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione

Chemical Name:2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione
CAS.NO:100208-62-6
Synonyms:2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione
Molecular Formula:C18H11NO2
Molecular Weight:273.28500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:47.03000
Exact Mass:273.07900
LogP:3.39760

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione Use and application,2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione technical grade,usp/ep/jp grade.


Related News: Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. 2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione manufacturer The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%. 2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione supplier Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. 2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione vendor Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. 2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione factory Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.